Myocardial protection in patients undergoing coronary artery bypass grafting surgery using minimized extracorporeal

Assad Haneya1, Alois Philipp, Claudius Diez

  • 1Department of Cardiothoracic Surgery, University Medical Center Regensburg, Regensburg, Germany. assadhaneya@web.de

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|January 20, 2011
PubMed

Insights

Minimally invasive extracorporeal circulation (ECC) with sevoflurane anesthesia (SEVO group) reduced myocardial damage during coronary artery bypass grafting (CABG). This approach also improved perfusion and lowered oxygen consumption during aortic cross-clamping (ACC).

Area of Science:

  • Cardiovascular Surgery
  • Anesthesiology
  • Biomedical Engineering

Background:

  • Minimally invasive extracorporeal circulation (ECC) offers a safer alternative to conventional ECC in coronary artery bypass grafting (CABG).
  • Anesthetic choices may impact ischemia-reperfusion injury during CABG surgery.

Purpose of the Study:

  • To evaluate the cardioprotective effects of two minimized ECC systems combined with different anesthetic strategies.
  • To assess the impact on oxygen consumption during aortic cross-clamping (ACC).

Main Methods:

  • Retrospective analysis of 1,182 patients undergoing elective isolated CABG with minimized ECC (2003-2008).
  • Patients received either sevoflurane-based volatile anesthesia (PRECiSe system) or propofol-based intravenous anesthesia (MECC system).

Main Results:

  • The sevoflurane group (SEVO) exhibited significantly lower postoperative myocardial creatine kinase levels (p < 0.001).
  • During ACC, the SEVO group had higher systemic vascular resistance (SVR) (p < 0.005) and lower oxygen consumption (p < 0.0001).

Conclusions:

  • The PRECiSe system with sevoflurane anesthesia appears to minimize myocardial cell damage post-CABG.
  • This combination potentially improves perfusion, increases SVR, and reduces oxygen demand during ACC.